The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Would be good news if it was Scardey and Robbo
https://www.medusa19.com/en/about-us/
Christian Stephenson has over 24 years experience in the medical devices industry. Working for a range of multinational blue-chip companies (Smith&Nephew, KCI, 3M ) and start-up / SME’s (Crawford Health Care & Lantor). His career has primarily focussed on R&D and strategic portfolio development, and building teams with market-leading track records of delivery. Christian’s last role was Vice President of R&D for KCI, the largest wound care company globally, where he was responsible for the whole wound care pipeline and global R&D team. Prior to this position, Christian led the R&D, Regulatory and Quality team at Crawford Healthcare, developing from scratch a wound care portfolio, which rapidly became the 3rd largest in the UK, with Kerrmax becoming the number 1 brand in the medical device market. Christian was part of the management team that ultimately led to the successful sale of Crawford.
Christian holds a degree in Chemistry from the University of Hull and has numerous publications and patents.
Alan McNally is Professor Microbial Evolutionary Genomics at The University of Birmingham - he set up the testing site for the uni and all its students last year. He is very pro LFT.
I have not read this yet, just about to but I thought you might all like to read it as well. Found on Twitter by Alan McNally. Published today.
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001216
https://twitter.com/alanmcn1/status/1387847937686921216
Perhaps they need to remember that Avacta can help with global testing - our market is not just the UK!
Brazil are in a terrible position with over 4200 deaths yesterday and 82000 new cases. People are not even going to hospital as they know there is no room for treatment or oxygen.
https://www.bbc.co.uk/news/world-latin-america-56657818
Absolutely Bodeswell. Worth a listen and is being recorded so if you miss it now you can listen later.
Try this link :
https://presentations.investormeetcompany.com/conferences/8ce1c6915bab/bigroom
What a fantastic interview.
We should all be very grateful to the exposure that Paul Hill at Vox Markets has given Avacta. His passion about the share has solicited a lot more information out of AS and thus helped many understand in greater detail what this company is about. It would be a huge loss if these interviews stopped because of some of the negativity of shareholders have shown.
All his interviews have allowed Avacta to showcase the bigger picture and detail what an exciting future it has. Keep up the great work Paul.
Steadyman, this is what Paul Hill said about his planned interview next week.
Myles McNulty asked to add in some questions too.
https://twitter.com/CapitalPmh/status/1368829120789020677
Energysharees, you are so right. Alastair is a straight forward man what was providing for his family of 6 at a time that was right for them.
As long term holders Dr Smith and his amazing team will enable us to buy our own houses and funnily enough rename them: AVACTA HOUSE!!!
This is great news for our Diagnostics Team - well done Avacta.
https://www.biokit.com/
Biokit, a Werfen company, is a recognized and renowned Center of Excellence with consolidated experience worldwide in research, development and manufacturing of Assay and Biomaterilal solutions for IVD use.